Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

With Large Biosimilars Opportunity In Sight, Multinational Companies Open Dialogue With India’s Wockhardt

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - Adversities are throwing up unexpected opportunities for the debt-ridden Indian drug maker Wockhardt. While the company is being helped to tide over its unprecedented financial crisis of $600 million in debts by a group of large Indian banks, strategic opportunities in its biotech businesses have now come to surface
Advertisement

Related Content

Wockhardt In Final Stages Of Talks To Sell German Operation To Lindo Pharm
Wockhardt In Final Stages Of Talks To Sell German Operation To Lindo Pharm
Investment Bank Rothschild Indicates Several Strong Points Of Cash-strapped Wockhardt
Investment Bank Rothschild Indicates Several Strong Points Of Cash-strapped Wockhardt
Unable To Manage Debts, India’s Wockhardt Calls For Financial Restructuring; Habil Khorakiwala Resigns As Managing Director
Unable To Manage Debts, India’s Wockhardt Calls For Financial Restructuring; Habil Khorakiwala Resigns As Managing Director
Advertisement
UsernamePublicRestriction

Register

SC071567

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel